KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Operations: 2015-2025

Historic Cash from Operations for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $246.2 million.

  • Medpace Holdings' Cash from Operations rose 65.16% to $246.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $711.2 million, marking a year-over-year increase of 23.79%. This contributed to the annual value of $608.8 million for FY2024, which is 40.48% up from last year.
  • Per Medpace Holdings' latest filing, its Cash from Operations stood at $246.2 million for Q3 2025, which was up 65.77% from $148.5 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Cash from Operations registered a high of $246.2 million during Q3 2025, and its lowest value of $46.3 million during Q1 2022.
  • Moreover, its 3-year median value for Cash from Operations was $148.5 million (2025), whereas its average is $142.1 million.
  • Per our database at Business Quant, Medpace Holdings' Cash from Operations tumbled by 32.80% in 2021 and then skyrocketed by 92.80% in 2022.
  • Quarterly analysis of 5 years shows Medpace Holdings' Cash from Operations stood at $70.9 million in 2021, then surged by 92.80% to $136.7 million in 2022, then climbed by 14.42% to $156.4 million in 2023, then rose by 21.91% to $190.7 million in 2024, then spiked by 65.16% to $246.2 million in 2025.
  • Its Cash from Operations was $246.2 million in Q3 2025, compared to $148.5 million in Q2 2025 and $125.8 million in Q1 2025.